Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing (NVDA:NASDAQ)

Iambic Therapeutics, an AI-driven drug discovery company backed by Nvidia (NVDA), filed for a U.S. initial public offering on Monday, seeking to list on the Nasdaq under the ticker IAM.

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

Sept 21 : Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of biotech listings in the fall window.While the fall IPO window has gotten off to a rocky start amid uncertainty surrounding t

Nvidia-Backed AI Drugmaker Iambic Therapeutics Files for IPO

Iambic Therapeutics Inc., a clinical-stage life sciences and technology firm that counts Nvidia Corp. as a shareholder, filed for a US initial public offering.

AI Drug Discovery Firm Iambic Therapeutics Plans Nasdaq Debut With Nvidia Backing

Iambic Therapeutics, backed by Nvidia and Qatar's wealth fund, files for Nasdaq IPO to raise $100M for AI-driven cancer drug development under ticker IAM.

Iambic Therapeutics files for US IPO with Nvidia backing

Iambic Therapeutics filed an S-1 for a Nasdaq IPO under ticker IAM, backed by Nvidia and other major investors after raising $461.8 million since